{"id":"temocapril","rwe":[{"pmid":"38399287","year":"2024","title":"Simultaneously Predicting the Pharmacokinetics of CES1-Metabolized Drugs and Their Metabolites Using Physiologically Based Pharmacokinetic Model in Cirrhosis Subjects.","finding":"","journal":"Pharmaceutics","studyType":"Clinical Study"},{"pmid":"37137721","year":"2023","title":"Evaluation of Drug-Drug Interactions via Inhibition of Hydrolases by Orlistat, an Anti-Obesity Drug.","finding":"","journal":"Drug metabolism and disposition: the biological fate of chemicals","studyType":"Clinical Study"},{"pmid":"37037169","year":"2023","title":"Generation of Caco-2 cells with predictable metabolism by CYP3A4, UGT1A1 and CES using the PITCh system.","finding":"","journal":"Drug metabolism and pharmacokinetics","studyType":"Clinical Study"},{"pmid":"36356070","year":"2022","title":"A Case of a Small-Breed Dog with Diet-Related Dilated Cardiomyopathy Showing Marked Improvements in Cardiac Morphology and Function after Dietary Modification.","finding":"","journal":"Veterinary sciences","studyType":"Clinical Study"},{"pmid":"36047192","year":"2022","title":"Intestinal Permeability of Drugs in Caco-2 Cells Cultured in Microfluidic Devices.","finding":"","journal":"Biological & pharmaceutical bulletin","studyType":"Clinical Study"}],"tags":[{"label":"temocapril","category":"class"},{"label":"Small Molecule","category":"modality"},{"label":"Angiotensin-converting enzyme","category":"target"},{"label":"ACE","category":"gene"},{"label":"C09AA14","category":"atc"},{"label":"Active","category":"status"},{"label":"Hypertensive disorder","category":"indication"},{"label":"Angiotensin-Converting Enzyme Inhibitors","category":"pharmacology"},{"label":"Antihypertensive Agents","category":"pharmacology"},{"label":"Cardiovascular Agents","category":"pharmacology"},{"label":"Enzyme Inhibitors","category":"pharmacology"},{"label":"Protease Inhibitors","category":"pharmacology"}],"phase":"marketed","safety":{},"trials":[],"aliases":[],"patents":[],"pricing":[],"_sources":{"trials":{"url":"https://clinicaltrials.gov/search?intr=TEMOCAPRIL","method":"api_direct","source":"ClinicalTrials.gov","rawText":"","confidence":1,"sourceType":"ctgov","retrievedAt":"2026-04-20T00:02:53.294816+00:00"},"regulatory.ca":{"url":"","method":"api_direct","source":"Health Canada DPD","rawText":"","confidence":1,"sourceType":"health_canada_dpd","retrievedAt":"2026-04-20T00:02:59.504535+00:00"},"publicationCount":{"url":"https://pubmed.ncbi.nlm.nih.gov/?term=TEMOCAPRIL","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-20T00:02:59.861233+00:00"},"crossReferences.chemblId":{"url":"https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2110627/","method":"api_direct","source":"ChEMBL (EMBL-EBI)","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T00:03:00.569964+00:00"}},"allNames":["temocapril","temocapril hydrochloride","CS-622","temocapril HCl"],"offLabel":[],"synonyms":["temocapril","temocapril hydrochloride","CS-622","temocapril HCl"],"timeline":[{"date":"1994-01-01","type":"positive","source":"DrugCentral","milestone":"YEAR INTRODUCED approval"}],"approvals":[{"date":"1994-01-01","orphan":false,"company":"","regulator":"YEAR INTRODUCED"}],"ecosystem":[{"indication":"Hypertensive disorder","otherDrugs":[{"name":"acebutolol","slug":"acebutolol","company":"Promius Pharma"},{"name":"aliskiren","slug":"aliskiren","company":"Novartis"},{"name":"amiloride","slug":"amiloride","company":"Paddock Llc"},{"name":"amlodipine","slug":"amlodipine","company":"Pfizer"}],"globalPrevalence":null}],"mechanism":{"target":"Angiotensin-converting enzyme","targets":[{"gene":"ACE","source":"DrugCentral","target":"Angiotensin-converting enzyme","protein":"Angiotensin-converting enzyme"}],"modality":"Small Molecule","drugClass":"temocapril","explanation":"","oneSentence":"","technicalDetail":"Temocapril is a competitive inhibitor of angiotensin-converting enzyme (ACE), which catalyzes the conversion of angiotensin I to angiotensin II. By inhibiting this conversion, temocapril reduces the levels of angiotensin II, leading to vasodilation and decreased blood pressure."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/2586","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://clinicaltrials.gov/search?intr=TEMOCAPRIL","fields":["trials"],"source":"ClinicalTrials.gov"},{"id":3,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=TEMOCAPRIL","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-30T15:49:45.554288","_validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T00:03:04.594916+00:00","fieldsConflicting":1,"overallConfidence":0.8},"biosimilars":[],"competitors":[{"drugName":"captopril","drugSlug":"captopril","fdaApproval":"1981-04-06","genericCount":21,"patentStatus":"Off-patent — generic available","relationship":"same-class"},{"drugName":"enalapril","drugSlug":"enalapril","fdaApproval":"1985-12-24","patentExpiry":"Nov 6, 2032","patentStatus":"Patent protected","relationship":"same-class"},{"drugName":"lisinopril","drugSlug":"lisinopril","fdaApproval":"1987-12-29","patentExpiry":"Nov 6, 2035","patentStatus":"Patent protected","relationship":"same-class"},{"drugName":"perindopril","drugSlug":"perindopril","fdaApproval":"1993-12-30","genericCount":5,"patentStatus":"Off-patent — generic available","relationship":"same-class"},{"drugName":"ramipril","drugSlug":"ramipril","fdaApproval":"1991-01-28","patentExpiry":"Aug 16, 2039","patentStatus":"Patent protected","relationship":"same-class"},{"drugName":"quinapril","drugSlug":"quinapril","fdaApproval":"1991-11-19","genericCount":12,"patentStatus":"Off-patent — generic available","relationship":"same-class"},{"drugName":"benazepril","drugSlug":"benazepril","fdaApproval":"1991-06-25","genericCount":12,"patentStatus":"Off-patent — generic available","relationship":"same-class"},{"drugName":"fosinopril","drugSlug":"fosinopril","fdaApproval":"1991-05-16","genericCount":10,"patentStatus":"Off-patent — generic available","relationship":"same-class"},{"drugName":"trandolapril","drugSlug":"trandolapril","fdaApproval":"1996-04-26","genericCount":10,"patentStatus":"Off-patent — generic available","relationship":"same-class"},{"drugName":"spirapril","drugSlug":"spirapril","fdaApproval":"1994-12-29","patentStatus":"Unknown","relationship":"same-class"},{"drugName":"moexipril","drugSlug":"moexipril","fdaApproval":"1995-04-19","genericCount":4,"patentStatus":"Off-patent — generic available","relationship":"same-class"}],"genericName":"temocapril","indications":{"approved":[{"name":"Hypertensive disorder","source":"DrugCentral","snomedId":38341003,"regulator":"FDA"}],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[{"drugId":"captopril","brandName":"captopril","genericName":"captopril","approvalYear":"1981","relationship":"same-class"},{"drugId":"enalapril","brandName":"enalapril","genericName":"enalapril","approvalYear":"1985","relationship":"same-class"},{"drugId":"lisinopril","brandName":"lisinopril","genericName":"lisinopril","approvalYear":"1987","relationship":"same-class"},{"drugId":"perindopril","brandName":"perindopril","genericName":"perindopril","approvalYear":"1993","relationship":"same-class"},{"drugId":"ramipril","brandName":"ramipril","genericName":"ramipril","approvalYear":"1991","relationship":"same-class"},{"drugId":"quinapril","brandName":"quinapril","genericName":"quinapril","approvalYear":"1991","relationship":"same-class"},{"drugId":"benazepril","brandName":"benazepril","genericName":"benazepril","approvalYear":"1991","relationship":"same-class"},{"drugId":"fosinopril","brandName":"fosinopril","genericName":"fosinopril","approvalYear":"1991","relationship":"same-class"},{"drugId":"trandolapril","brandName":"trandolapril","genericName":"trandolapril","approvalYear":"1996","relationship":"same-class"},{"drugId":"spirapril","brandName":"spirapril","genericName":"spirapril","approvalYear":"1994","relationship":"same-class"}],"trialDetails":[{"nctId":"NCT07262710","phase":"","title":"Association of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers With Post-Stroke Pneumonia: A Real-World Retrospective Cohort Study","status":"NOT_YET_RECRUITING","sponsor":"First Teaching Hospital of Tianjin University of Traditional Chinese Medicine","startDate":"2025-12-01","conditions":["Post-stroke Pneumonia"],"enrollment":13656,"completionDate":"2026-08-19"}],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"crossReferences":{"NDDF":"010988","UNII":"18IZ008EU6","CHEBI":"CHEBI:32190","INN_ID":"6712","UMLSCUI":"C0753183","chemblId":"CHEMBL2110627","ChEMBL_ID":"CHEMBL2110627","KEGG_DRUG":"D01119","DRUGBANK_ID":"DB08836","PUBCHEM_CID":"443874","IUPHAR_LIGAND_ID":"11736","SECONDARY_CAS_RN":"110221-44-8","MESH_SUPPLEMENTAL_RECORD_UI":"C055603"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[],"publicationCount":172,"therapeuticAreas":["Cardiovascular"],"atcClassification":{"source":"DrugCentral","atcCode":"C09AA14","allCodes":["C09AA14"]},"biosimilarFilings":[],"recentPublications":[{"date":"2024 Feb 5","pmid":"38399287","title":"Simultaneously Predicting the Pharmacokinetics of CES1-Metabolized Drugs and Their Metabolites Using Physiologically Based Pharmacokinetic Model in Cirrhosis Subjects.","journal":"Pharmaceutics"},{"date":"2023 Aug","pmid":"37137721","title":"Evaluation of Drug-Drug Interactions via Inhibition of Hydrolases by Orlistat, an Anti-Obesity Drug.","journal":"Drug metabolism and disposition: the biological fate of chemicals"},{"date":"2023 Jun","pmid":"37037169","title":"Generation of Caco-2 cells with predictable metabolism by CYP3A4, UGT1A1 and CES using the PITCh system.","journal":"Drug metabolism and pharmacokinetics"},{"date":"2022 Oct 27","pmid":"36356070","title":"A Case of a Small-Breed Dog with Diet-Related Dilated Cardiomyopathy Showing Marked Improvements in Cardiac Morphology and Function after Dietary Modification.","journal":"Veterinary sciences"},{"date":"2022","pmid":"36047192","title":"Intestinal Permeability of Drugs in Caco-2 Cells Cultured in Microfluidic Devices.","journal":"Biological & pharmaceutical bulletin"}],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","brandName":"TEMOCAPRIL","companyName":"","companyId":"","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Temocapril is a small molecule with a mechanism of action related to angiotensin converting enzyme inhibitors and angiotensin receptor blockers. It has been studied in a real-world retrospective cohort study for its association with post-stroke pneumonia.","enrichmentLevel":3,"visitCount":0,"regulatoryByCountry":[{"country_code":"OTHER","regulator":"YEAR INTRODUCED","status":"approved","approval_date":"1994-01-01T00:00:00.000Z","mah":"","brand_name_local":null,"application_number":""},{"country_code":"CA","regulator":"Health Canada","status":"approved","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":0,"withResults":0},"validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T00:03:04.594916+00:00","fieldsConflicting":1,"overallConfidence":0.8},"verificationStatus":"partial","dataCompleteness":{"mechanism":false,"indications":true,"safety":false,"trials":true,"score":2}}